Amedisys, Inc. (AMED)

Amedisys Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	138.86	54.13	45.77	83.36	96.49
Cash & Cash Equivalents	138.86	54.13	45.77	83.36	96.49
Cash Growth	156.52%	18.27%	-45.09%	-13.61%	376.99%
Receivables	313.37	296.79	274.96	255.15	237.6
Other Current Assets	44.7	38.04	35.95	23.48	16.47
Total Current Assets	496.94	388.96	356.68	361.98	350.55
Property, Plant & Equipment	130.78	118.88	119.69	117.16	112.9
Goodwill and Intangibles	1,347	1,389	1,307	1,007	723.25
Other Long-Term Assets	85.1	79.84	73.31	81.19	76.04
Total Long-Term Assets	1,563	1,587	1,500	1,205	912.19
Total Assets	2,060	1,976	1,857	1,567	1,263
Accounts Payable	28.24	43.74	38.22	42.67	31.26
Current Debt	62.6	49.02	44.23	40.54	37.7
Other Current Liabilities	382.88	262.78	291.84	373.12	257.99
Total Current Liabilities	473.72	355.53	374.28	456.34	326.94
Long-Term Debt	424.61	488.92	501.38	266.5	288.38
Other Long-Term Liabilities	42.05	25.22	4.98	33.62	5.91
Total Long-Term Liabilities	466.67	514.14	506.36	300.12	294.29
Total Liabilities	940.39	869.67	880.65	756.46	621.23
Total Debt	487.21	537.94	545.61	307.04	326.08
Debt Growth	-9.43%	-1.41%	77.70%	-5.84%	4314.24%
Retained Earnings	747.93	757.67	639.06	429.99	246.38
Comprehensive Income	0	0	0	0	0.02
Shareholders' Equity	1,067	1,052	931.35	809.22	640.45
Net Cash / Debt	-348.35	-483.81	-499.84	-223.68	-229.59
Net Cash Per Share	-10.69	-14.82	-15.16	-6.72	-6.96
Working Capital	23.21	33.43	-17.6	-94.35	23.61
Book Value Per Share	32.72	32.34	28.53	24.85	19.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).